Showing 571-580 of 834 results for "".
- Opus Genetics Announces Two Leadership Appointmentshttps://modernod.com/news/opus-genetics-announces-two-leadership-appointments/2480367/Opus Genetics announced two key appointments to its founding executive team. Ash Jayagopal, PhD, has joined the company as Chief Scientific Officer (CSO); and Joe Schachle has joined as Chief Operating Officer (COO). “We were thrilled to launch Opus last month to advance an A
- PulseSight Therapeutics to Present New Data on Iron Dysregulation and Ferroptosis in AMD at Euretina 2025https://modernod.com/news/pulsesight-therapeutics-to-present-new-data-on-iron-dysregulation-and-ferroptosis-in-amd-at-euretina-2025/2484133/PulseSight Therapeutics announced that its Chief Scientific Officer, Thierry Bordet, PhD, will present new clinical and preclinical findings on the role of iron dysregulation and ferroptosis in age-related macular degeneration (AMD) at the 25th Euretina Congre
- ViaLase Announces Strategic Leadership Transitionshttps://modernod.com/news/vialase-announces-strategic-leadership-transitions/2482876/ViaLase announced changes to its executive leadership team as the company prepares for commercial launch and regulatory approvals in both the United States and Europe. Tibor Juhasz, PhD, founder and former Chief Executive Officer, has transitioned to
- Scientists Use Gene Editing to Treat Retinitis Pigmentosa in Micehttps://modernod.com/news/scientists-use-gene-editing-to-treat-retinitis-pigmentosa-in-mice/2482558/Researchers funded by the National Eye Institute (NEI) have successfully used a gene-editing technique to correct a mutation responsible for retinitis pigmentosa (RP). The study, led by Krzysztof Palczewski, PhD, of the University of California
- New Study Unveils How Immune Cells Defend the Eye Against Inflammationhttps://modernod.com/news/new-study-unveils-how-immune-cells-defend-the-eye-against-inflammation/2482470/In a new study, researchers led by Sue Menko, PhD, of Thomas Jefferson University, have revealed how immune cells play a critical role in resolving inflammation on the surface of the eye’s lens. Published in The American Journal of
- University of Toronto Researchers Build Online Glaucoma Simulatorhttps://modernod.com/news/university-of-toronto-researchers-build-online-glaucoma-simulator/2481843/Researchers at the University of Toronto have built an online simulator that is designed to give an improved visual representation of the deterioration caused by glaucoma. The simulator, built by Prof. Willy Wong and PhD candidat
- Researchers Identify Potential Cause of Keratoconushttps://modernod.com/news/researchers-identify-potential-cause-of-keratoconus/2481402/Researchers at the University of North Texas Health Science Center are the first to characterize extracellular vesicles (EVs) in the tears of patients with keratoconus, according to an National Eye Institute news release. Dimitrios Karamichos, PhD, executive director of the North
- Illinois Tech Researcher Awarded $2.5 Million Grant to Prevent Vision Loss in Diabetes Patientshttps://modernod.com/news/illinois-tech-researcher-awarded-2-5-million-grant-to-prevent-vision-loss-in-diabetes-patients/2479432/Illinois Institute of Technology Professor of Biomedical Engineering Jennifer Kang-Mieler, PhD. has received a second research project grant (R01) from the National Institutes of Health to study diabetic retinopathy.
- EyePoint Pharmaceuticals Names New Members of Executive Leadership Teamhttps://modernod.com/news/eyepoint-pharmaceuticals-names-new-members-of-executive-leadership-team/2476642/EyePoint Pharmaceuticals announced the appointment of Scott Jones as Chief Commercial Officer and Said Saim, PhD, as Chief Technology Officer. Mr. Jones will be responsible for the commercialization of Dexycu (dexamethasone intraocular suspension) 9% for the treatment of postoperative inflammatio
- Oculis Elects Anthony Rosenberg and David A. Weber to Its Board of Directorshttps://modernod.com/news/oculis-elects-anthony-rosenberg-and-david-a-weber-to-its-board-of-directors/2479867/Oculis announced the appointments of Anthony Rosenberg as Non-Executive Chairman and David A. Weber, PhD, as Non-Executive Director. Together, they bring more than 60 years’ experience from the global pharmaceutical and eye care industries to the compa